Navigation Links
Kantar Health Launches CancerMPact Biomarker Analysis
Date:5/23/2013

New York, NY (PRWEB) May 23, 2013

Kantar Health, a leading global healthcare advisory firm, today announced the availability of CancerMPact® Biomarker Analysis, a global offer that examines biomarker segmentation in the current and evolving oncology landscape. The analysis is based on a thorough review of literature and recently published data covering the following biomarkers:

*BRAF (melanoma)

*EGFR (non-small lung cancer)

*EML4-ALK (non-small cell lung cancer)

*KRAS (colorectal cancer)

*TNBC (breast cancer)

CancerMPact Biomarker Analysis helps clients identify the percentage of cancer patients with a specific biomarker; ascertain variations in biomarker prevalence by race, ethnicity or geography; determine which information to use to inform forecasting and market sizing; and pinpoint which patient segments are available for targeted therapies and clinical trials. Through this new offer, pharma companies are able to better understand which patient subpopulations are candidates for unique treatment options in this complex therapeutic area.

“The era of ‘personalized’ medicine has arrived, and while physicians and patients are ready to embrace it, many factors need to be considered by a manufacturer to accurately evaluate their market opportunities,” Kantar Health Vice President David Robinson said. “We estimate that 17 to 20 percent of oncology patients are currently eligible for personalized care due to either biomarkers or histology-based treatments. This number will grow in the near future as more biomarkers are validated and new patient subpopulations are identified as being appropriate for novel targeted therapeutics.”

CancerMPact Biomarker Analysis is produced by the same oncology experts as CancerMPact®, which has become an invaluable oncology decision support tool for market analysis, strategic planning and identification of commercial opportunities in the U.S., Western Europe, Japan and China. This tool, composed of web-based integrated modules, includes Treatment Practices and Evolution (Treatment Architecture and Future Trends and Insights), Patient Metrics, and Monthly Drugs and Regimens.

About Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10755248.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
2. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
3. Kantar Health to Present at PBIRG Annual General Meeting
4. AACR honors Hagop Kantarjian for outstanding clinical research
5. Kantar Health to Participate in CIO Summit of America Conference
6. Kantar Health Further Strengthens Its Advanced Methods and Client Consulting Capabilities in the UK
7. Bel Marra Health Reports on a New Study Revealing Health Benefits From Walking Barefoot
8. Max! Healthy Vending Machines in Tune with Burgeoning Organic Foods Market
9. Zane Benefits Publishes New Information on Alabama Health Insurance Exchange
10. Why We Cant Wait: Conference to Eliminate Health Disparities in Genomic Medicine
11. How To "Make Your Own Healthy Energy Bars"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... The iaedp Foundation, recognized ... treatment providers who treat the full spectrum of eating disorder problems, proudly announces ... Council consists of the leading eating disorder treatments centers located throughout the U.S. ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... University is taught by healthcare management and evaluation leaders with decades of experience ... to pay-for-value in the United States healthcare system, there is a renewed demand ...
(Date:1/23/2017)... ... 23, 2017 , ... The American Academy of Thermology ... development, healthcare training and clinical application of medical infrared imaging, has announced the ... Qualification Courses for Technicians, respectively. , For the first time the AAT is ...
(Date:1/23/2017)... ... 2017 , ... METTLER TOLEDO has announced the availability of ... PAT Tools . , Crystallization is a common step used during ... Chemists now spend more time developing better intermediate and final crystallization steps. ...
(Date:1/23/2017)... ... January 23, 2017 , ... Steviva Ingredients, makers of all-natural ... USDA National Organic Program (NOP) for its Portland SQF Level 2 manufacturing facility. ... and handling systems to complement our current rigorous food-safety management systems,” said Yishu ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... The American Pharmacists Association (APhA) is excited ... Medically Underserved Areas Enhancement Act (H.R. 592) ... was previously introduced in the 114 th session ... through pharmacists and their patient care services. ... (R-KY), G.K. Butterfield (D-NC), Tom ...
(Date:1/23/2017)... ALBANY, New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn ... by expanding at a strong 17.50% CAGR between 2014 and 2022. ... - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: